FABP1 and Cirrhosis: In a recent study including 444 hospitalized patients with decompensated cirrhosis, Juanola and colleagues demonstrated, that urinary fatty-acid-binding-protein (L-FABP) levels, as an indirect marker of hepatic inflammation, were independently associated with the 3-month clinical course in patients with decompensated cirrhosis, in terms of mortality and ACLF development.